Robert I. Nicholson

23.8k total citations · 3 hit papers
262 papers, 18.4k citations indexed

About

Robert I. Nicholson is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Robert I. Nicholson has authored 262 papers receiving a total of 18.4k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Genetics, 127 papers in Oncology and 105 papers in Molecular Biology. Recurrent topics in Robert I. Nicholson's work include Estrogen and related hormone effects (122 papers), HER2/EGFR in Cancer Research (82 papers) and Breast Cancer Treatment Studies (31 papers). Robert I. Nicholson is often cited by papers focused on Estrogen and related hormone effects (122 papers), HER2/EGFR in Cancer Research (82 papers) and Breast Cancer Treatment Studies (31 papers). Robert I. Nicholson collaborates with scholars based in United Kingdom, United States and Australia. Robert I. Nicholson's co-authors include Julia M.W. Gee, M. E. Harper, Ian O. Ellis, J.F.R. Robertson, KM Taylor, Denise Barrow, R.W. Blamey, Stephen Hiscox, Janice M. Knowlden and Iain R. Hutcheson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Robert I. Nicholson

257 papers receiving 17.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EGFR and cancer prognosis

2001 1.7k citations Robert I. Nicholson, Julia M.W. Gee et al. profile →
Expression and amplification of cyclin genes in human breast cancer.

1993 583 citations Robert I. Nicholson, Elizabeth A. Musgrove et al. PubMed profile →
A prognostic index in primary breast cancer

1982 527 citations J. L. Haybittle, C.W. Elston et al. British Journal of Cancer profile →

Peers

Robert I. Nicholson

ONCOL

GENET

PRM

J.F.R. Robertson United Kingdom

Robert L. Sutherland Australia

Suzanne A.W. Fuqua United States

Andres J. Klein–Szanto United States

Robert B. Dickson United States

H. Shelton Earp United States

John T. Isaacs United States

Tito Fojo United States

Shinzaburo Noguchi Japan

Paul Dent United States

J.F.R. Robertson United Kingdom

Robert I. Nicholson

8.7k ×0.9

ONCOL

4.8k ×0.6

5.0k ×1.0

GENET

5.7k ×1.3

4.2k ×1.5

PRM

Citations per year, relative to Robert I. Nicholson Robert I. Nicholson (= 1×) peers J.F.R. Robertson

Countries citing papers authored by Robert I. Nicholson

Since Specialization

Citations

This map shows the geographic impact of Robert I. Nicholson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Nicholson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Nicholson more than expected).

Fields of papers citing papers by Robert I. Nicholson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert I. Nicholson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Nicholson. The network helps show where Robert I. Nicholson may publish in the future.

Co-authorship network of co-authors of Robert I. Nicholson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert I. Nicholson. A scholar is included among the top collaborators of Robert I. Nicholson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert I. Nicholson. Robert I. Nicholson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thewes, Verena, Ronald Simon, Magdalena Schlotter, et al.. (2015). Reprogramming of the ERRα and ERα Target Gene Landscape Triggers Tamoxifen Resistance in Breast Cancer. Cancer Research. 75(4). 720–731. 35 indexed citations

Stone, Andrew, Mark J. Cowley, Fátima Valdés‐Mora, et al.. (2013). BCL-2 Hypermethylation Is a Potential Biomarker of Sensitivity to Antimitotic Chemotherapy in Endocrine-Resistant Breast Cancer. Molecular Cancer Therapeutics. 12(9). 1874–1885. 39 indexed citations

Smith, Christopher R., Lindy Goddard, Nicola Jordan, et al.. (2013). Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response. Endocrine Related Cancer. 20(5). 691–704. 31 indexed citations

Gee, Julia M.W., Robert I. Nicholson, Denise Barrow, et al.. (2011). Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance. Hormone Molecular Biology and Clinical Investigation. 5(2). 67–77. 6 indexed citations

Law, Jennifer, Golareh Habibi, Kaiji Hu, et al.. (2008). Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival. Cancer Research. 68(24). 10238–10246. 339 indexed citations

Hurtado, Antoni, Kelly A. Holmes, Timothy R. Geistlinger, et al.. (2008). Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen. Nature. 456(7222). 663–666. 239 indexed citations

Hiscox, Stephen & Robert I. Nicholson. (2008). Src inhibitors in breast cancer therapy. Expert Opinion on Therapeutic Targets. 12(6). 757–767. 28 indexed citations

Hutcheson, Iain R., Julia M.W. Gee, Denise Barrow, et al.. (2004). Treatment of tamoxifen-resistant MCF-7 breast cancer cells with either gefitinib ('Iressa') or trastuzumab (Herceptin((R))) generates cross-resistant phenotypes [Abstract]. Breast Cancer Research and Treatment. 2 indexed citations

Gee, Julia M.W., et al.. (2004). Characterization of ER alpha and cofactor recruitment during fulvestrant treatment and resistance in breast cancer using chromatin immunoprecipitation [Abstract]. Breast Cancer Research and Treatment. 1 indexed citations

10.

Knowlden, Janice M., Iain R. Hutcheson, Helen E. Jones, et al.. (2003). Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells. Endocrinology. 144(3). 1032–1044. 432 indexed citations

11.

Glynne-Jones, E, M. E. Harper, Liam T. Seery, et al.. (2001). TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. International Journal of Cancer. 94(2). 178–184. 50 indexed citations

12.

Crew, A. Jayne, Julia M.W. Gee, Rina Hui, et al.. (2000). Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation withGRB2 expression. International Journal of Cancer. 88(3). 363–368. 55 indexed citations

13.

Seery, Liam T., Janice M. Knowlden, Julia M.W. Gee, et al.. (1999). BRCA1 expression levels predict distant metastasis of sporadic breast cancers. International Journal of Cancer. 84(3). 258–262. 3 indexed citations

14.

Willsher, Peter C., S Pinder, Julia M.W. Gee, et al.. (1999). C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer.. PubMed. 18(5B). 3695–8. 25 indexed citations

15.

Eliopoulos, Aristides G., Demetrios�� Spandidos, David Barnes, et al.. (1995). Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. British Journal of Cancer. 72(5). 1259–1266. 130 indexed citations

16.

Nicholson, Robert I., et al.. (1990). Postfinishing mineralization of skeletal tissue in replacement gilts. Kansas Agricultural Experiment Station Research Reports. 72–75.

17.

Nicholson, Robert I., David A. Nichols, Joe D Hancock, et al.. (1989). Space requirements of finishing pigs fed to an average pen weight of 250 pounds. Kansas Agricultural Experiment Station Research Reports. 157–159. 1 indexed citations

18.

Leclercq, Guy, Hans Bojar, J Goussard, et al.. (1986). Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.. PubMed. 46(8 Suppl). 4233s–4236s. 73 indexed citations

19.

Nicholson, Robert I., K. Griffiths, R.W. Blamey, H Bishop, & J. L. Haybittle. (1981). Estrogen receptors and breast cancer.. Environmental Health Perspectives. 38. 143–146. 4 indexed citations

20.

Blamey, R.W., H Bishop, C.W. Elston, et al.. (1980). Relationship between primary breast tumor receptor status and patient survival. Cancer. 46(S12). 2765–2769. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact